Skip to main content
Honasa Consumer Limited logo

Honasa Consumer Limited — Investor Relations & Filings

Ticker · HONASA ISIN · INE0J5401028 LEI · 2549004POI9PD5S9GC46 BSE.NS Manufacturing
Open in API
Filings indexed 295 across all filing types
Latest filing 2024-03-01 Regulatory Filings
Country IN India
Listing BSE.NS HONASA

About Honasa Consumer Limited

https://honasa.in/

Honasa Consumer Limited is a digital-first platform that manages a diverse portfolio of consumer brands. The company specializes in the development and distribution of products through a house-of-brands strategy. Its portfolio includes Mamaearth, which emphasizes natural ingredients; The Derma Co., focused on science-backed skincare; Aqualogica, specializing in hydration; Ayuga, incorporating Ayurvedic traditions; BBlunt, a professional hair care range; and Dr. Sheth's, offering dermatologist-formulated solutions. The organization utilizes data-driven insights for product innovation and maintains a multi-channel distribution network. Its core focus involves addressing specific consumer needs through specialized formulations and a strong digital-led engagement model.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the listing departments of the National Stock Exchange of India and BSE Limited, referencing a corrigendum of a postal ballot notice. It mentions Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which govern disclosures by listed companies. The content includes newspaper advertisement cuttings related to the corrigendum of the postal ballot notice and states that the same is available on the company's website. There is no financial data, management discussion, or detailed report content. The document is essentially an announcement or disclosure about the corrigendum notice publication, not the notice itself or any financial report. It is also not a voting result declaration but a corrigendum to a postal ballot notice. Given the nature of the document as a regulatory disclosure announcement under SEBI regulations, it fits best under Regulatory Filings (RNS).
2024-03-01 English
Updates
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a corrigendum to a Postal Ballot Notice dated December 22, 2023, issued by Honasa Consumer Limited. It provides additional information and clarifications related to the explanatory statement of the postal ballot notice, specifically about the number of stock options to be granted and equity shares to be issued under employee stock option plans. The document references regulatory compliance under SEBI regulations and the Companies Act, 2013, and is addressed to shareholders and stock exchanges. It does not contain financial statements, earnings data, or management discussion and analysis. Instead, it is an official announcement correcting and supplementing a previously issued postal ballot notice, which is a solicitation for shareholder votes on specific resolutions. Therefore, this document is best classified as a Proxy Solicitation & Information Statement (PSI) related filing, specifically a corrigendum to a proxy solicitation document.
2024-02-28 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated February 28, 2024, from Honasa Consumer Limited addressed to stock exchanges. It announces the launch of the third season of the 'Beautiful Indians 2024' initiative by Femina and Mamaearth, highlighting the event details, participation information, and quotes from company and partner representatives. There is no financial data, regulatory filing, management discussion, or report attached or referenced. The document is a corporate announcement of a marketing and social initiative, not a financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2024-02-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an investor call held on February 9, 2024, discussing the company's un-audited financial results for the quarter and nine months ended December 31, 2023. It includes detailed management commentary on financial performance, business strategy, and Q&A with analysts. The text explicitly mentions it is a transcript of the earnings conference call, which is a typical format for Call Transcripts (CT). The document length is substantial (15,000 characters), and it contains the full text of the call, not just an announcement or summary. Therefore, it fits the definition of a Call Transcript (CT).
2024-02-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about the company's participation in upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document does not contain any financial data, report content, or detailed presentation materials. It is an announcement of an event (investor meet participation) rather than a report or transcript. Given the nature and length (1626 characters), it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2024-02-13 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the utilisation of funds raised through an Initial Public Offer (IPO). It confirms that there is no deviation or variation in the use of IPO proceeds for the quarter ended December 31, 2023. The letter references compliance with SEBI regulations and includes a detailed statement of deviation/variation in fund utilisation, reviewed by the Audit Committee and signed by the Company Secretary. The content is regulatory in nature, reporting on fund utilisation compliance rather than presenting financial results or detailed financial statements. It is not an annual or interim report, earnings release, or audit report. It is also not a report publication announcement since it contains substantive information. The document fits best under Regulatory Filings (RNS) as it is a compliance disclosure related to IPO fund utilisation under SEBI regulations.
2024-02-13 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.